Littérature scientifique sur le sujet « Cadmium, blood-brain barrier, neurodegenerative diseases »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Cadmium, blood-brain barrier, neurodegenerative diseases ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Cadmium, blood-brain barrier, neurodegenerative diseases"
Branca, Jacopo Junio Valerio, Mario Maresca, Gabriele Morucci, Tommaso Mello, Matteo Becatti, Luigia Pazzagli, Ilaria Colzi et al. « Effects of Cadmium on ZO-1 Tight Junction Integrity of the Blood Brain Barrier ». International Journal of Molecular Sciences 20, no 23 (29 novembre 2019) : 6010. http://dx.doi.org/10.3390/ijms20236010.
Texte intégralBressler, Joseph P., Luisa Olivi, Jae Hoon Cheong, Yongbae Kim, Alex Maerten et Desmond Bannon. « Metal transporters in intestine and brain : their involvement in metal-associated neurotoxicities ». Human & ; Experimental Toxicology 26, no 3 (mars 2007) : 221–29. http://dx.doi.org/10.1177/0960327107070573.
Texte intégralKakaroubas, Nicholas, Samuel Brennan, Matthew Keon et Nitin K. Saksena. « Pathomechanisms of Blood-Brain Barrier Disruption in ALS ». Neuroscience Journal 2019 (10 juillet 2019) : 1–16. http://dx.doi.org/10.1155/2019/2537698.
Texte intégralWeber, Callie M., et Alisa Morss Clyne. « Sex differences in the blood–brain barrier and neurodegenerative diseases ». APL Bioengineering 5, no 1 (1 mars 2021) : 011509. http://dx.doi.org/10.1063/5.0035610.
Texte intégralKaramanos, Yannis, Fabien Gosselet, Marie-Pierre Dehouck et Roméo Cecchelli. « Blood–Brain Barrier Proteomics : Towards the Understanding of Neurodegenerative Diseases ». Archives of Medical Research 45, no 8 (novembre 2014) : 730–37. http://dx.doi.org/10.1016/j.arcmed.2014.11.008.
Texte intégralWu, Ying-Chieh, Tuuli-Maria Sonninen, Sanni Peltonen, Jari Koistinaho et Šárka Lehtonen. « Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells ». International Journal of Molecular Sciences 22, no 14 (19 juillet 2021) : 7710. http://dx.doi.org/10.3390/ijms22147710.
Texte intégralSharma, Chanchal, Hanwoong Woo et Sang Ryong Kim. « Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease ». Biomedicines 10, no 4 (22 mars 2022) : 742. http://dx.doi.org/10.3390/biomedicines10040742.
Texte intégralCui, Weitong, Wei Fu, Yunfeng Lin et Tianxu Zhang. « Application of Nanomaterials in Neurodegenerative Diseases ». Current Stem Cell Research & ; Therapy 16, no 1 (1 décembre 2021) : 83–94. http://dx.doi.org/10.2174/1574888x15666200326093410.
Texte intégralSilva Adaya, Daniela, Lucinda Aguirre-Cruz, Jorge Guevara et Emma Ortiz-Islas. « Nanobiomaterials’ applications in neurodegenerative diseases ». Journal of Biomaterials Applications 31, no 7 (11 novembre 2016) : 953–84. http://dx.doi.org/10.1177/0885328216659032.
Texte intégralFang, Yao-Ching, Yi-Chen Hsieh, Chaur-Jong Hu et Yong-Kwang Tu. « Endothelial Dysfunction in Neurodegenerative Diseases ». International Journal of Molecular Sciences 24, no 3 (2 février 2023) : 2909. http://dx.doi.org/10.3390/ijms24032909.
Texte intégralThèses sur le sujet "Cadmium, blood-brain barrier, neurodegenerative diseases"
Leoni, Valerio. « On the possible use of oxysterols for the diagnosis and evaluation of patients with neurological and neurodegenerative diseases / ». Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-255-1/.
Texte intégralCarrino, Donatello. « Effetti biologici dell'esposizione cronica al cadmio sulla barriera emato-encefalica ». Doctoral thesis, 2022. http://hdl.handle.net/2158/1263776.
Texte intégralRibeiro, Adriana Marques. « Relatório de Estágio em Farmácia Comunitária e Monografia intitulada “The Role of the Blood-Brain Barrier and the Application of Nanomedicines in Neurodegenerative Diseases” ». Master's thesis, 2019. http://hdl.handle.net/10316/88332.
Texte intégralA Faculdade de Farmácia da Universidade de Coimbra, através do Mestrado Integrado em Ciências Farmacêuticas, tem como objetivo preparar os alunos para o desenvolvimento de atividades relacionadas com o medicamento e com a Saúde. Uma das áreas fundamentais, e também das mais antigas, com origem nos antigos boticários e nas suas boticas, é a Farmácia de Oficina ou, como atualmente é conhecida, a Farmácia Comunitária. “Comunitária” advém de comunidade, na sua capacidade de destinatária da ação farmacêutica, englobada no objetivo da promoção do bem-estar e da saúde e não apenas da ausência da doença. O relatório de estágio, elaborado sob a forma de análise SWOT visa expor a experiência do estágio em Farmácia Comunitária, realizado na Sucursal de Coimbra do Laboratório Militar de Produtos Químicos e Farmacêuticas no decorrer do último ano do mestrado. As Doenças Neurodegenerativas são um conjunto de doenças que afetam os neurónios do Sistema Nervoso Central. Exemplos destas doenças são a Doença de Parkinson e a Doença de Alzheimer. Estas patologias tomam conta da vida dos pacientes que as detêm e são obstáculo à existência de uma vida em pleno devido à degeneração progressiva do sistema nervoso e consequentes sintomas. A descoberta de terapêuticas realmente eficazes pode vir a revolucionar o dia-a-dia dos doentes e das pessoas que os rodeiam. Uma aproximação terapêutica possível é a Nanomedicina, que recorre a sistemas de escala nanométrica. Estes podem contornar obstáculos fisiológicos como a Barreira Hematoencefálica, uma barreira que tem como função proteger, mas também que se torna um desafio à passagem de terapêuticas convencionais.A presente monografia pretende abordar os desafios impostos pela Barreira Hematoencefálica como barreira física à passagem de terapêuticas convencionais e quais os nanosistemas atualmente descritos que podem vir a ser promessas na terapêutica das Doenças Neurodegenerativas.
The Faculty of Pharmacy of the University of Coimbra, through the Integrated Master in Pharmaceutical Sciences, has the aim to prepare the students for the development of activities related to Health and Medicines.One of the fundamental areas and one of the oldest ones, dated back to the old apothecaries, is Community Pharmacy. This area relates us to Community, the recipient of the pharmacist’s role in providing health care, trough the promotion of health and well-being and not only by the absence of disease. The internship report, based on SWOT analysis, gives an overlook about the experience of the Internship in Community Pharmacy, carried out in the Military Laboratory of Chemical and Pharmaceutical Products, in Coimbra’s branch, over the course of the last academic year of the Integrated Master. Neurodegenerative Diseases are a group of conditions that affect neurons of the Central Nervous System. Examples of these diseases are Parkinson's Disease and Alzheimer's Disease. These pathologies take care of the life of the patients and do not allow them to have a full life due to the progressive degeneration of the nervous system and consequent symptoms. The discovery of truly effective therapies can revolutionize the day-to-day lives of patients and those around them.One possible therapeutic approach is Nanomedicine, which uses nanoscale systems that can circumvent physiological obstacles such as the Blood-Brain Barrier, a barrier which function is to protect but also becomes a challenge to the passage of conventional therapies.The present monograph aims to address the challenges posed by the Blood-Brain Barrier as a physical obstacle to the passage of conventional therapies and the currently described nanosystems can be promising in the therapy of Neurodegenerative Diseases.
Livres sur le sujet "Cadmium, blood-brain barrier, neurodegenerative diseases"
Di, Liegro Italia, et Savettieri Giovanni, dir. Molecular bases of neurodegeneration, 2005. Kerala, India : Research Signpost, 2005.
Trouver le texte intégralGupta, Anil. Blood-Brain Barrier in Neurodegenerative Diseases : New Perspectives in Neuropathology. Elsevier Science & Technology Books, 2024.
Trouver le texte intégralChapitres de livres sur le sujet "Cadmium, blood-brain barrier, neurodegenerative diseases"
Youdim, M. B. H., K. L. Leenders et D. Ben-Shachar. « Brain Iron Uptake and Transport in Animal Model of Iron Deficiency, Tardive Dyskinesia and Neurodegenerative Diseases ». Dans Blood—Brain Barrier, 147–56. Boston, MA : Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-0579-2_12.
Texte intégralPeschanski, Marc. « Prospects for Neuroprotective Gene Therapy for Neurodegenerative Diseases ». Dans Biology and Physiology of the Blood-Brain Barrier, 9–10. Boston, MA : Springer US, 1996. http://dx.doi.org/10.1007/978-1-4757-9489-2_2.
Texte intégralRibatti, Domenico. « Mast Cells in Blood-Brain Barrier Alterations and Neurodegenerative Diseases ». Dans The Mast Cell, 67–74. Cham : Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-24190-2_8.
Texte intégralMaher, Barbara A. « Airborne Magnetite- and Iron-Rich Pollution Nanoparticles : Potential Neurotoxicants and Environmental Risk Factors for Neurodegenerative Disease, Including Alzheimer’s Disease ». Dans Advances in Alzheimer’s Disease. IOS Press, 2021. http://dx.doi.org/10.3233/aiad210006.
Texte intégralKrishnan, Anuradha, Hao Wu et Venkat Venkataraman. « Astrocytic S100B, Blood-Brain Barrier and Neurodegenerative Diseases ». Dans Glia in Health and Disease. IntechOpen, 2020. http://dx.doi.org/10.5772/intechopen.92146.
Texte intégralBraun, Molly, et Jeffrey J. Iliff. « The impact of neurovascular, blood-brain barrier, and glymphatic dysfunction in neurodegenerative and metabolic diseases ». Dans International Review of Neurobiology, 413–36. Elsevier, 2020. http://dx.doi.org/10.1016/bs.irn.2020.02.006.
Texte intégralKonofagou, Elisa E. « Blood–Brain Barrier Opening and Drug Delivery Using Focused Ultrasound and Microbubbles ». Dans Neurobiology of Mental Illness, sous la direction de Karl Deisseroth, 148–59. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199934959.003.0011.
Texte intégralAdams, Jr., Ph.D., James D. « DNA, Nuclear Cell Signaling and Neurodegeneration ». Dans Extracellular and Intracellular Signaling, 175–87. The Royal Society of Chemistry, 2011. http://dx.doi.org/10.1039/bk9781849733434-00175.
Texte intégralKumar Chatterjee, Swapan, Snigdha Saha et Shahin Muhammed T.K. « COVID-19 and Its Impact on Onset and Progression of Parkinson’s and Cognitive Dysfunction ». Dans COVID-19 Pandemic, Mental Health and Neuroscience - New Scenarios for Understanding and Treatment [Working Title]. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.105667.
Texte intégralHornedo-Ortega, Ruth, Zuriñe Rasines-Perea, Ana B. Cerezo, Pierre-Louis Teissedre et Michael Jourdes. « Anthocyanins : Dietary Sources, Bioavailability, Human Metabolic Pathways, and Potential Anti-Neuroinflammatory Activity ». Dans Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.99927.
Texte intégralActes de conférences sur le sujet "Cadmium, blood-brain barrier, neurodegenerative diseases"
Kim, Jung Hwan, Thomas H. Mareci et Malisa Sarntinoranont. « Computational Model of Interstitial Transport in the Rat Brain Using Diffusion Tensor Imaging ». Dans ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176633.
Texte intégral